A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
520 patients around the world
Available in Puerto Rico, Brazil, United States
Eli Lilly and Company
4Research sites
520Patients around the world
This study is for people with
Diabetes
Diabetes mellitus type 2
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
L2IP Instituto de Pesquisas Clínicas
SGAS 613, Conj. E Bloco A , Sala 06 - Subsolo , Asa Sul - Brasília/DF, CEP: 70.200-730
Cedoes - Pesquisa e Diagnóstico
R. João da Silva Abreu, 78 - Praia do Canto, Vitória - ES, 29055-450
CEMEC - Centro Multidisciplinar de Estudos Clínicos
R. Silva Jardim, 187 - 63 - Centro, São Bernardo do Campo - SP, 09715-090, Brazil
Instituto Brasil de Pesquisa Clínica - IBPClin
R. da Glória, 344 - Glória, Rio de Janeiro - RJ, 20241-180
